Literature DB >> 22358653

Characterization and fed-batch culture of hybridoma overexpressing apoptosis suppressing gene bcl-2.

S Terada1, Y Itoh, H Ueda, E Suzuki.   

Abstract

Mouse hybridoma 2E3 transfected with human bcl-2 gene survived longer with increasing expression level of bcl-2 when cultured in DME medium supplemented with 9% serum. One of the transfectants, 2E3BCMGbcl-2, overexpressed bcl-2 and could maintain viable cell density higher than the initial density for more than four days at a low 0.5% serum concentration. In comparison a mock transfectant 2E3BCMG remained viable for only one day. However, both hybridomas died out within a day in serum-free medium. These results suggested that bcl-2 needed a small amount of some serum components to suppress apoptosis of the hybridoma. Overexpression of bcl-2 also suppressed apoptosis of the hybridoma induced by glutamine deprivation. When hybridoma 2E3BCMGbcl-2 was inoculated in DME medium supplemented with 9% serum and cultured for 10 d with additional 2% serum feed at day 4 of the culture, viable cell density increased 2-fold and antibody produced 3-fold, in comparison with mock transfected 2E3 cultured in the same manner. The mock transfectant with additional feed of serum at day 4 of the culture showed no difference in viable cell density and antibody production. These results suggested that the mock transfectant committed to apoptosis before day 4 of the culture and the additional serum at day 4 could not reverse the commitment.

Entities:  

Year:  1997        PMID: 22358653      PMCID: PMC3449577          DOI: 10.1023/A:1007922104344

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  16 in total

1.  Enhanced antibody production at slowed growth rates: experimental demonstration and a simple structured model.

Authors:  E Suzuki; D F Ollis
Journal:  Biotechnol Prog       Date:  1990 May-Jun

2.  Cell death in bioreactors: a role for apoptosis.

Authors:  R P Singh; M Al-Rubeai; C D Gregory; A N Emery
Journal:  Biotechnol Bioeng       Date:  1994-09-05       Impact factor: 4.530

3.  Growth rate suppression of cultured mammalian cells enhances protein productivity.

Authors:  K Takahashi; S Tereda; H Ueda; F Makishima; E Suzuki
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

4.  Essential role of optimal protein synthesis in preventing the apoptotic death of cultured B cell hybridomas.

Authors:  J Perreault; R Lemieux
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

5.  Kinetics of development of spontaneous apoptosis in B cell hybridoma cultures.

Authors:  T Vomastek; F Franĕk
Journal:  Immunol Lett       Date:  1993-01       Impact factor: 3.685

6.  Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.

Authors:  D L Vaux; S Cory; J M Adams
Journal:  Nature       Date:  1988-09-29       Impact factor: 49.962

7.  Mathematical descriptions of hybridoma culture kinetics: I. Initial metabolic rates.

Authors:  M W Glacken; E Adema; A J Sinskey
Journal:  Biotechnol Bioeng       Date:  1988-08-05       Impact factor: 4.530

8.  Induction of apoptosis in nutrient-deprived cultures of hybridoma and myeloma cells.

Authors:  S Mercille; B Massie
Journal:  Biotechnol Bioeng       Date:  1994-11-05       Impact factor: 4.530

9.  Expression of the bcl-2 gene in human multiple myeloma cell lines and normal plasma cells.

Authors:  M Pettersson; H Jernberg-Wiklund; L G Larsson; C Sundström; I Givol; Y Tsujimoto; K Nilsson
Journal:  Blood       Date:  1992-01-15       Impact factor: 22.113

10.  Growth autonomy and tumorigenicity of interleukin 6-dependent B cells transfected with interleukin 6 cDNA.

Authors:  N Tohyama; H Karasuyama; T Tada
Journal:  J Exp Med       Date:  1990-02-01       Impact factor: 14.307

View more
  1 in total

1.  Co-expression of bcl-2 and bag-1, apoptosis suppressing genes, prolonged viable culture period of hybridoma and enhanced antibody production.

Authors:  S Terada; T Komatsu; T Fujita; A Terakawa; T Nagamune; S Takayama; J C Reed; E Suzuki
Journal:  Cytotechnology       Date:  1999-09       Impact factor: 2.058

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.